Literature DB >> 4067733

An immunohistological study of giant-cell tumour of bone: evidence for an osteoclast origin of the giant cells.

N A Athanasou, E Bliss, K C Gatter, A Heryet, C G Woods, J O McGee.   

Abstract

Using a panel of monoclonal antibodies against a variety of lymphoid and non-lymphoid antigens the immunohistological staining pattern of giant cells from a case of giant-cell tumour of bone has been compared with that of osteoclasts from the developing ends of fetal long bones. Only EBM-11, an antibody reacting with a wide spectrum of macrophages, stained both osteoclasts and giant cells; stromal cells and osteoblasts did not react. This indicates that osteoclasts and giant cells are phenotypically and presumably functionally similar. It is argued that the osteoclasts and the tumour-derived giant cells in bone are derived from a similar mononuclear precursor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067733     DOI: 10.1002/path.1711470302

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  14 in total

1.  Labelling of cells of the mononuclear phagocyte system in routinely processed archival biopsy specimens with monoclonal antibody EBM/11.

Authors:  G I Greywoode; S P McCarthy; J O McGee
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.

Authors:  L Huang; J Xu; D J Wood; M H Zheng
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Histogenetic characterization of giant cell tumor of bone.

Authors:  Manuela Salerno; Sofia Avnet; Marco Alberghini; Armando Giunti; Nicola Baldini
Journal:  Clin Orthop Relat Res       Date:  2008-06-10       Impact factor: 4.176

4.  Immunophenotype of multinucleated and mononuclear cells in giant cell lesions of bone and soft tissue.

Authors:  I A Doussis; B Puddle; N A Athanasou
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

5.  Monoclonal antibody EBM/11: high cellular specificity for human macrophages.

Authors:  P M Kelly; E Bliss; J A Morton; J Burns; J O McGee
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

6.  Histopathological, immunohistochemical, and image analytic parameters characterizing the stromal component in primary and recurrent giant cell tumor of bone.

Authors:  Charu Chandra Saxena; Rajni Safaya; Neha Kawatra Madan; Shah Alam Khan; Venkateswaran K Iyer
Journal:  J Clin Orthop Trauma       Date:  2015-10-26

7.  Histiocytic differentiation in benign and malignant bone tumors.

Authors:  A Meyer; T Steinmeier; T Löning; H J Radzun; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

8.  Immunocytochemical analysis of HLA class II (DR) antigens in liver disease in man.

Authors:  C Barbatis; P Kelly; J Greveson; A Heryet; J O McGee
Journal:  J Clin Pathol       Date:  1987-08       Impact factor: 3.411

9.  Immunohistochemical study of mononuclear phagocyte antigens in giant cell tumor of bone.

Authors:  M E Brecher; W A Franklin; M A Simon
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

Review 10.  RANKL/RANK/OPG: key therapeutic target in bone oncology.

Authors:  Kosei Ando; Kanji Mori; Francoise Rédini; Dominique Heymann
Journal:  Curr Drug Discov Technol       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.